Novo Nordisk(NVO)
$41.63+0.98 (+2.41%)
NVO
Novo Nordisk financials statements
$41.63
At close:+0.98 (+2.41%)
Want to see NVO full AI Analyst Report?
Novo Nordisk (NVO) Income Statement
15,212 Followers
Novo Nordisk Income Statement
Last quarter (Q3 2026), Novo Nordisk's total revenue was kr79.19B, an increase of 5.63% from the same quarter last year. In Q3, Novo Nordisk's net income was kr16.74B. See Novo Nordisk’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 309.06B | kr 290.40B | kr 232.26B | kr 176.95B | kr 140.80B | |
| kr 250.28B | kr 245.88B | kr 196.50B | kr 148.51B | kr 117.14B | |
| kr 122.62B | kr 117.54B | kr 93.92B | kr 73.70B | kr 58.50B | |
| Depreciation and Amortization | kr 21.98B | kr 19.11B | kr 9.41B | kr 7.36B | kr 6.03B |
| kr 156.73B | kr 147.94B | kr 114.63B | kr 76.80B | kr 65.39B | |
| kr 127.66B | kr 128.34B | kr 102.57B | kr 74.81B | kr 58.64B | |
| kr 2.88B | kr -1.15B | kr 2.10B | kr -5.75B | kr 436.00M | |
| kr 130.54B | kr 127.19B | kr 104.67B | kr 69.06B | kr 59.08B | |
| kr 102.43B | kr 100.99B | kr 83.68B | kr 55.52B | kr 47.76B | |
| Per Share Metrics | |||||
| Basic EPS | kr 23.06 | kr 22.67 | kr 18.67 | kr 12.26 | kr 10.40 |
| Diluted EPS | kr 23.03 | kr 22.63 | kr 18.62 | kr 12.22 | kr 10.37 |
| Weighted Average Shares Outstanding | 4.45B | 4.45B | 4.48B | 4.53B | 4.59B |
| Weighted Average Shares Outstanding (Diluted) | 4.45B | 4.46B | 4.49B | 4.54B | 4.61B |
Currency in DKK

